381MO Durability of clinical benefit and biomarkers in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with AMG 510 (sotorasib) D.S. Hong, Y-J. Bang, F. Barlesi, G. Durm, G.S. Falchook,R. Govindan,G.K. Dy, K. Park, J.H. Strickler,T.F. Burns,J. Kim,A. Ang, J.R. Lipford, G. Ngarmchamnanrith,A. Anderson,B.T. LiAnnals of Oncology（2020）引用 2|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
